Protara Therapeutics Management
Management criteria checks 3/4
Protara Therapeutics' CEO is Jesse Shefferman, appointed in Jan 2020, has a tenure of 4.75 years. total yearly compensation is $1.91M, comprised of 31.9% salary and 68.1% bonuses, including company stock and options. directly owns 4.01% of the company’s shares, worth €1.33M. The average tenure of the management team and the board of directors is 2.8 years and 4.8 years respectively.
Key information
Jesse Shefferman
Chief executive officer
US$1.9m
Total compensation
| CEO salary percentage | 31.9% |
| CEO tenure | 4.8yrs |
| CEO ownership | 4.0% |
| Management average tenure | 2.8yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$41m |
| Mar 31 2024 | n/a | n/a | -US$42m |
| Dec 31 2023 | US$2m | US$608k | -US$40m |
| Sep 30 2023 | n/a | n/a | -US$69m |
| Jun 30 2023 | n/a | n/a | -US$67m |
| Mar 31 2023 | n/a | n/a | -US$64m |
| Dec 31 2022 | US$3m | US$588k | -US$66m |
| Sep 30 2022 | n/a | n/a | -US$37m |
| Jun 30 2022 | n/a | n/a | -US$40m |
| Mar 31 2022 | n/a | n/a | -US$45m |
| Dec 31 2021 | US$4m | US$570k | -US$47m |
| Sep 30 2021 | n/a | n/a | -US$46m |
| Jun 30 2021 | n/a | n/a | -US$43m |
| Mar 31 2021 | n/a | n/a | -US$37m |
| Dec 31 2020 | US$8m | US$507k | -US$34m |
| Sep 30 2020 | n/a | n/a | -US$28m |
| Jun 30 2020 | n/a | n/a | -US$22m |
| Mar 31 2020 | n/a | n/a | -US$16m |
| Dec 31 2019 | US$379k | US$344k | -US$8m |
| Sep 30 2019 | n/a | n/a | -US$7m |
| Dec 31 2018 | US$301k | US$268k | -US$4m |
Compensation vs Market: Jesse's total compensation ($USD1.91M) is above average for companies of similar size in the German market ($USD503.65K).
Compensation vs Earnings: Jesse's compensation has been consistent with company performance over the past year.
CEO
Jesse Shefferman (52 yo)
4.8yrs
Tenure
US$1,906,132
Compensation
Mr. Jesse Shefferman serves as Chief Executive Officer, President and Director of Protara Therapeutics, Inc. (Formerly known as Proteon Therapeutics Inc.) since January 2020. He Co-founded Protara Therapeu...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-founder | 4.8yrs | US$1.91m | 4.01% $ 1.3m | |
| Co-Founder | 3.8yrs | US$1.04m | 0.31% $ 101.5k | |
| Chief Financial Officer | 1.8yrs | US$1.44m | 0% $ 0 | |
| VP, Principal Accounting Officer & Controller | 2.3yrs | no data | 0.083% $ 27.3k | |
| Senior Vice President of Investor Relations & Corporate Affairs | 2.8yrs | no data | no data | |
| General Counsel & Corporate Secretary | 2.8yrs | no data | no data |
2.8yrs
Average Tenure
47.5yo
Average Age
Experienced Management: 1KPA's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-founder | 4.8yrs | US$1.91m | 4.01% $ 1.3m | |
| Independent Chairman of the Board | 6yrs | US$192.26k | 0.15% $ 48.1k | |
| Independent Director | 4.8yrs | US$118.26k | 0.15% $ 49.7k | |
| Independent Director | 4.8yrs | US$75.76k | 0% $ 0 | |
| Independent Director | 4.8yrs | US$71.76k | 0% $ 0 | |
| Independent Director | 4.8yrs | US$91.76k | 0% $ 0 | |
| Independent Director | 3.8yrs | US$72.76k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$66.76k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$85.76k | 0% $ 0 |
4.8yrs
Average Tenure
58yo
Average Age
Experienced Board: 1KPA's board of directors are considered experienced (4.8 years average tenure).